Cardiomyopathy Trial, Recruiting (NCT03049254)

Cardiomyopathy Trial, Recruiting NCT03049254 Sponsor: Mayo Clinic Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT03049254 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You survived a sudden cardiac arrest (heart suddenly stopping) that was NOT caused by a heart attack
A family member died suddenly from cardiac arrest that was NOT caused by a heart attack, and you are involved in their case
You had a sudden cardiac arrest that happened alongside seizures, epilepsy, fainting, drowning, or near-drowning, and doctors suspect a heart muscle problem may be involved
You are a close family member of someone who has been diagnosed with a primary heart muscle disease (such as hypertrophic cardiomyopathy, dilated cardiomyopathy, or arrhythmogenic ventricular cardiomyopathy)

Who may not be able to join:

Your cardiac arrest or sudden cardiac death had a clear, confirmed cause, such as a heart attack or heart failure caused by blocked arteries
You have significant blockages in the heart's arteries (more than 50% narrowed) that could clearly explain any weakness in your heart's pumping function
You are unwilling or unable to provide written agreement to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Virend Somers, PhD, MD, Mayo Clinic

Phone: +1 507 2558794

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03049254

Sponsor: Mayo Clinic

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: +1 507 2558794

More information: https://clinicaltrials.gov/study/NCT03049254

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You survived a sudden cardiac arrest (heart suddenly stopping) that was NOT caused by a heart attack
A family member died suddenly from cardiac arrest that was NOT caused by a heart attack, and you are involved in their case
You had a sudden cardiac arrest that happened alongside seizures, epilepsy, fainting, drowning, or near-drowning, and doctors suspect a heart muscle problem may be involved
You are a close family member of someone who has been diagnosed with a primary heart muscle disease (such as hypertrophic cardiomyopathy, dilated cardiomyopathy, or arrhythmogenic ventricular cardiomyopathy)

Who may not be able to join:

Your cardiac arrest or sudden cardiac death had a clear, confirmed cause, such as a heart attack or heart failure caused by blocked arteries
You have significant blockages in the heart's arteries (more than 50% narrowed) that could clearly explain any weakness in your heart's pumping function
You are unwilling or unable to provide written agreement to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Mayo Clinic

Registry

ClinicalTrials.gov

Start date

9 February 2018

Est. completion

1 March 2027

Where this trial is recruiting

🇬🇧 United Kingdom 🇺🇸 United States

Primary endpoints

Genotyping; Correlate genotype with phenotype

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov